- Home
- WAFU vs ENSC Comparison
WAFU vs ENSC Comparison
Compare WAFU & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- ENSC
- Stock Information
- Founded
- WAFU 1999
- ENSC 2003
- Country
- WAFU China
- ENSC United States
- Employees
- WAFU N/A
- ENSC N/A
- Industry
- WAFU Other Consumer Services
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- ENSC Health Care
- Exchange
- WAFU Nasdaq
- ENSC Nasdaq
- Market Cap
- WAFU 6.5M
- ENSC 6.4M
- IPO Year
- WAFU 2019
- ENSC N/A
- Fundamental
- Price
- WAFU $1.69
- ENSC $2.10
- Analyst Decision
- WAFU
- ENSC
- Analyst Count
- WAFU 0
- ENSC 0
- Target Price
- WAFU N/A
- ENSC N/A
- AVG Volume (30 Days)
- WAFU 1.1M
- ENSC 54.6K
- Earning Date
- WAFU 01-01-0001
- ENSC 11-11-2025
- Dividend Yield
- WAFU N/A
- ENSC N/A
- EPS Growth
- WAFU N/A
- ENSC N/A
- EPS
- WAFU N/A
- ENSC N/A
- Revenue
- WAFU $6,186,645.00
- ENSC $7,413,722.00
- Revenue This Year
- WAFU N/A
- ENSC N/A
- Revenue Next Year
- WAFU N/A
- ENSC $1,354.55
- P/E Ratio
- WAFU N/A
- ENSC N/A
- Revenue Growth
- WAFU N/A
- ENSC 415.58
- 52 Week Low
- WAFU $1.22
- ENSC $1.62
- 52 Week High
- WAFU $7.49
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- WAFU 57.01
- ENSC 48.61
- Support Level
- WAFU $1.58
- ENSC $2.02
- Resistance Level
- WAFU $1.90
- ENSC $2.19
- Average True Range (ATR)
- WAFU 0.29
- ENSC 0.10
- MACD
- WAFU 0.02
- ENSC 0.00
- Stochastic Oscillator
- WAFU 12.82
- ENSC 41.45
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.